Form4insider filings, from the source

SEC Form 4 · accession 0000904454-15-000680

ACHILLION PHARMACEUTICALS INC · ACHN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Nov 9, 2015S318,551$10.01D2,545,176IBy Domain Partners VIII, L.P.
Common StockF1,F4Nov 9, 2015S2,375$10.01D18,874IBy DP VIII Associates, L.P.
Common StockF2,F4Nov 10, 2015S177,749$10.43D2,367,427IBy Domain Partners VIII, L.P.
Common StockF2,F4Nov 10, 2015S1,325$10.43D17,549IBy DP VIII Associates, L.P.
Common StockF3,F4Nov 11, 2015S49,630$10.31D2,317,797IBy Domain Partners VIII, L.P.
Common StockF3,F4Nov 11, 2015S370$10.31D17,179IBy DP VIII Associates, L.P.
Common StockF4holding———25,000IBy Domain Associates, LLC
Common Stockholding———31,431D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses